Abzena

About Abzena:

Abzena is the leading end-to-end bioconjugate and complex biologics CDMO + CRO. From discovery through commercial launch, we support customers with fully integrated programs or individual services designed to de-risk and streamline the development of new treatments for patients in need. With the ability to tailor its strategy and customer experience to each project, Abzena develops and implements innovative solutions that enable biotech and biopharma companies to realize the full potential of th...eir molecule and move medicines forward faster. The company has research, development, and cGMP facilities located in San Diego, CA; Bristol, PA; and Cambridge, UK. Abzena is owned by Welsh, Carson, Anderson & Stowe, one of the world’s leading private equity investors.

Service Offerings:

Design & Synthesis of Linker-Payloads
Complex Chemistry
High Potency Handling (HPAPIs)
cGMP Bioconjugate development and manufacturing for ADCs
AOCs
RDCs
PDCs
Nanoparticle- Drug Conjugates
Conjugate Vaccines
protein cross-linking
PEGylation
oligo- and liposome- bioconjugation
synthesis of complex molecules and novel payloads
Design and optimization of synthetic routes that provide an efficient
scalable
and robust process for production of both non-GMP and cGMP payloads
payload-linker and complex small molecule production
GMP manufacturing of final ADC conjugates and other bioconjugates for preclinical
Phase 1
2
3 clinical trials
GMP suite utilizes single-use technology in the bioconjugation suite
Support up to 500L batch sizes
analytical method development